Archives for December 14, 2009

← 2009

TNO to move into Phase 0 studies with AMS buy

By Gareth Macdonald

Netherlands-based contract research group TNO has purchased an accelerator mass spectrometer (AMS) to add microdosing to its clinical trial offering.

Avid’s Q2 revenues rise 440%

By Nick Taylor

CMO Avid Bioservices’ year-on-year revenues increased by 440 per cent in the second quarter, leading to the company planning expansions in Asia-Pacific, biosimilars and analytical services.